Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inari Medical, Inc. (NARI)
NASDAQ:NARI
Holding NARI?
Track your performance easily
NARI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$36.73 - $67.10
Previous Close$55.59
Volume1.10M
Average Volume (3M)916.94K
Market Cap
$3.25B
Enterprise Value$3.18B
Total Cash (Recent Filing)$111.54M
Total Debt (Recent Filing)$32.72M
Price to Earnings (P/E)―
Beta-0.05
Next Earnings
Mar 04, 2025EPS Estimate
-$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.35
Shares Outstanding58,544,158
10 Day Avg. Volume1,183,356
30 Day Avg. Volume916,939
Standard Deviation0.13
R-Squared0.12
Alpha-0.00193
Financial Highlights & Ratios
Price to Book (P/B)7.48
Price to Sales (P/S)5.66
Price to Cash Flow (P/CF)300.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.53
Enterprise Value/Gross Profit7.31
Enterprise Value/Ebitda-89.92
Forecast
1Y Price Target
$63.75Price Target Upside12.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Inari Medical News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement raised its FY24 revenue guidance by $3.5M at the midpoint to a range of $601.5M-$604.5M, slightly ahead of pre-print.
Market Position And GrowthInari is the leading player in the U.S. venous thromboembolism market with its ClotTriever and FlowTriever mechanical thrombectomy systems.
Product SuperiorityThe trial results showed less clinical deterioration and less use of intensive care for patients using FlowTriever compared to catheter-directed thrombolysis.
Bears Say
Financial PerformanceGAAP EPS missed consensus.
Legal And Regulatory IssuesThere is an ongoing DOJ investigation with no clear resolution timeline, which could cause disruption.
Market CompetitionShares have been under pressure due to ongoing concerns over the increasingly competitive landscape within the company's VTE thrombectomy business.
---
Ownership Overview
11.03% Insiders
29.09% Mutual Funds
25.75% Other Institutional Investors
8.63% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NARI FAQ
What was Inari Medical, Inc.’s price range in the past 12 months?
Inari Medical, Inc. lowest stock price was $36.73 and its highest was $67.10 in the past 12 months.
What is Inari Medical, Inc.’s market cap?
Currently, no data Available
When is Inari Medical, Inc.’s upcoming earnings report date?
Inari Medical, Inc.’s upcoming earnings report date is Mar 04, 2025 which is in 73 days.
How were Inari Medical, Inc.’s earnings last quarter?
Inari Medical, Inc. released its earnings results on Oct 28, 2024. The company reported -$0.084 earnings per share for the quarter, beating the consensus estimate of -$0.116 by $0.032.
Is Inari Medical, Inc. overvalued?
According to Wall Street analysts Inari Medical, Inc.’s price is currently Undervalued.
Does Inari Medical, Inc. pay dividends?
Inari Medical, Inc. does not currently pay dividends.
What is Inari Medical, Inc.’s EPS estimate?
Inari Medical, Inc.’s EPS estimate is -$0.03.
How many shares outstanding does Inari Medical, Inc. have?
Inari Medical, Inc. has 58,544,160 shares outstanding.
What happened to Inari Medical, Inc.’s price movement after its last earnings report?
Inari Medical, Inc. reported an EPS of -$0.084 in its last earnings report, beating expectations of -$0.116. Following the earnings report the stock price went up 15.555%.
Which hedge fund is a major shareholder of Inari Medical, Inc.?
Among the largest hedge funds holding Inari Medical, Inc.’s share is Harbourvest Partners Llc. It holds Inari Medical, Inc.’s shares valued at 2M.
---
Inari Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$63.75 (12.33% Upside)
$63.75 (12.33% Upside)
Blogger Sentiment
Bullish
NARI Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 120.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.0%
Last 30 Days ▼ 4.6%
Last 30 Days ▼ 4.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.49%
12-Months-Change
Fundamentals
Return on Equity
-17.72%
Trailing 12-Months
Asset Growth
27.04%
Trailing 12-Months
Company Description
Inari Medical, Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States.
---
NARI Company Deck
---
NARI Earnings Call
Q3 2024
0:00 / 0:00
---
NARI Revenue Breakdown
96.48% VTE
3.52% Emerging Therapies
---
NARI Stock 12 Month Forecast
Average Price Target
$63.75
▲(12.33% Upside)
Technical Analysis
Best Analysts Covering NARI
1 Year
1 Year Success Rate
6/10 ratings generated profit
1 Year Average Return
+2.95%
reiterated a buy rating 2 months ago
Copying Travis Steed's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +2.95% per trade.
---